Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancer

Takahiko Sakaue(Kurume University), Takuji Torimura(Kurume University)

Medical Molecular Morphology

February 25, 2019

10.1007/s00795-019-00218-5

Cited by 62

Related Papers

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT)

|PLoS ONE|2020|84

Promotion of liver regeneration and anti‑fibrotic effects of the TGF‑β receptor kinase inhibitor galunisertib in CCl4‑treated mice

|International Journal of Molecular Medicine|2020|32

Impact of Decorin on the Physical Function and Prognosis of Patients with Hepatocellular Carcinoma

|Journal of Clinical Medicine|2020|27